Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Pre- and Post-Administration of 80 mg Atorvastatin on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in STEMI Patients Undergoing Primary PCI

NCT06871358 is registered in ClinicalTrials.gov with Universitas Sebelas Maret as lead sponsor.

NCT NCT06871358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Pre- and Post-Administration of 80 mg Atorvastatin on Hs-CRP/Albumin Ratio in Reducing Thrombus Burden in STEMI Patients Undergoing Primary PCI
Lead sponsor
Universitas Sebelas Maret
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2024
Completion date
November 20, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary pci for stemi, stemi (ste-acs)